221 related articles for article (PubMed ID: 24913913)
21. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
Kwon H; Kim YH; Choi JY; Shin S; Jung JH; Park SK; Han DJ
Clin Transplant; 2018 Jun; 32(6):e13266. PubMed ID: 29676812
[TBL] [Abstract][Full Text] [Related]
22. Specificity, strength, and evolution of pretransplant donor-specific HLA antibodies determine outcome after kidney transplantation.
Senev A; Lerut E; Van Sandt V; Coemans M; Callemeyn J; Sprangers B; Kuypers D; Emonds MP; Naesens M
Am J Transplant; 2019 Nov; 19(11):3100-3113. PubMed ID: 31062492
[TBL] [Abstract][Full Text] [Related]
23. Tailored immunosuppression after kidney transplantation - a single center real-life experience.
Good-Weber M; Roos M; Mueller TF; Rüsi B; Fehr T
BMC Nephrol; 2020 Nov; 21(1):501. PubMed ID: 33228545
[TBL] [Abstract][Full Text] [Related]
24. De Novo Donor-Specific Human Leukocyte Antigen Antibody Screening in Kidney Transplant Recipients After the First Year Posttransplantation: A Medical Decision Analysis.
Kiberd BA; Miller A; Martin S; Tennankore KK
Am J Transplant; 2016 Nov; 16(11):3212-3219. PubMed ID: 27106124
[TBL] [Abstract][Full Text] [Related]
25. Kidney paired donation in the presence of donor-specific antibodies.
Blumberg JM; Gritsch HA; Reed EF; Cecka JM; Lipshutz GS; Danovitch GM; McGuire S; Gjertson DW; Veale JL
Kidney Int; 2013 Nov; 84(5):1009-16. PubMed ID: 23715120
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
27. Characterizing the risk of human leukocyte antigen-incompatible living donor kidney transplantation in older recipients.
Long JJ; Motter JD; Jackson KR; Chen J; Orandi BJ; Montgomery RA; Stegall MD; Jordan SC; Benedetti E; Dunn TB; Ratner LE; Kapur S; Pelletier RP; Roberts JP; Melcher ML; Singh P; Sudan DL; Posner MP; El-Amm JM; Shapiro R; Cooper M; Verbesey JE; Lipkowitz GS; Rees MA; Marsh CL; Sankari BR; Gerber DA; Wellen JR; Bozorgzadeh A; Gaber AO; Heher EC; Weng FL; Djamali A; Helderman JH; Concepcion BP; Brayman KL; Oberholzer J; Kozlowski T; Covarrubias K; Massie AB; McAdams-DeMarco MA; Segev DL; Garonzik-Wang JM
Am J Transplant; 2023 Dec; 23(12):1980-1989. PubMed ID: 37748554
[TBL] [Abstract][Full Text] [Related]
28. The role of the altruistic unbalanced chain in exchange living donor renal transplantation: single-center experience.
Ahn BK; Kwon OJ; Kang CM
Transplant Proc; 2012 Jan; 44(1):17-21. PubMed ID: 22310567
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
[TBL] [Abstract][Full Text] [Related]
30. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations.
Ko Y; Kim JY; Kim SH; Kim DH; Lim SJ; Shin S; Kim YH; Jung JH; Park SK; Kwon H; Han DJ
Ann Transplant; 2020 Oct; 25():e927420. PubMed ID: 33020465
[TBL] [Abstract][Full Text] [Related]
31. Outcomes, complications, and economic impact of ABO-incompatible living kidney transplantation: A single-center Japanese cohort study.
Kakuta Y; Okumi M; Unagami K; Iizuka J; Takagi T; Ishida H; Tanabe K
Clin Transplant; 2019 Jun; 33(6):e13591. PubMed ID: 31077450
[TBL] [Abstract][Full Text] [Related]
32. Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)-Infected Recipients.
Shelton BA; Mehta S; Sawinski D; Reed RD; MacLennan PA; Gustafson S; Segev DL; Locke JE
Am J Transplant; 2017 Jan; 17(1):173-179. PubMed ID: 27305590
[TBL] [Abstract][Full Text] [Related]
33. Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients.
Sawinski D; Shelton BA; Mehta S; Reed RD; MacLennan PA; Gustafson S; Segev DL; Locke JE
Am J Transplant; 2017 Dec; 17(12):3114-3122. PubMed ID: 28696079
[TBL] [Abstract][Full Text] [Related]
34. Quantifying renal allograft loss following early antibody-mediated rejection.
Orandi BJ; Chow EH; Hsu A; Gupta N; Van Arendonk KJ; Garonzik-Wang JM; Montgomery JR; Wickliffe C; Lonze BE; Bagnasco SM; Alachkar N; Kraus ES; Jackson AM; Montgomery RA; Segev DL
Am J Transplant; 2015 Feb; 15(2):489-98. PubMed ID: 25611786
[TBL] [Abstract][Full Text] [Related]
35. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
[TBL] [Abstract][Full Text] [Related]
36. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
37. Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study.
Webber S; Zeevi A; Mason K; Addonizio L; Blume E; Dipchand A; Shaddy R; Feingold B; Canter C; Hsu D; Mahle W; Armstrong B; Morrison Y; Ikle D; Diop H; Odim J;
Am J Transplant; 2018 Sep; 18(9):2148-2162. PubMed ID: 29673058
[TBL] [Abstract][Full Text] [Related]
38. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
39. Inferior long-term allograft and patient outcomes among recipients of offspring living donor kidneys.
Cohen JB; Owei L; Sawinski DL; Porrett PM
Am J Transplant; 2018 Jul; 18(7):1699-1709. PubMed ID: 29266831
[TBL] [Abstract][Full Text] [Related]
40. Long-term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation: A Comparative Analysis.
Shin E; Kwon SW; Yang WS; Baeck C; Yu H; Cho H; Park SK
Transplant Proc; 2015; 47(6):1720-6. PubMed ID: 26293040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
